Howe Jolanda sold $327K of MIRM
Howe Jolanda (SVP, GLOBAL CONTROLLER) sold 2,721 shares of Mirum Pharmaceuticals, Inc. (MIRM) at $120.00 ($0.33M total) on 2026-07-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the specific open-market sale size, price, and that it was executed under a pre-arranged 10b5-1 plan.
Market read
Traders may note the disclosed insider selling, but 10b5-1 status typically makes it a low-signal catalyst.
What to watch
The article provides only one insider sale; without context on prior insider trades, total insider net activity, or company performance, signal strength is limited.
Background
This is an SEC Form 4 insider transaction disclosure for Mirum Pharmaceuticals, Inc. (MIRM).
Ticker impact
Mirum Pharmaceuticals Form 4 shows SVP Global Controller Howe Jolanda sold 2,721 shares at $120 on 2026-07-01 under a 10b5-1 plan.
Low near-term impact; any effect is likely absorbed as non-informational selling.
The filing is a disclosed open-market sale with an explicit pre-arranged 10b5-1 plan, reducing interpretive value for near-term fundamentals.
Market effects
No sector read-through; this is company-specific insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, repeated insider selling can coincide with internal risk management or diversification needs; monitor for clustering versus isolated sales.
Key entities
- issuerMirum Pharmaceuticals, Inc.
Subject of the Form 4 insider transaction; SVP Global Controller sold shares under a 10b5-1 plan.
- insiderHowe Jolanda
SVP, Global Controller; sold 2,721 shares at $120 on 2026-07-01.
